Polymorphism of the DNA repair gene ERCC2 Lys751Gln and risk of lung cancer in a northeastern Chinese population

Cancer Genetics and Cytogenetics

Volumn 169, Issue 1, 2006, Pages 27-32

  Yin, Jiaoyang ^a   Vogel, Ulla ^b   Ma, Yegang ^c   Guo, Li ^a   Wang, Huiwen ^a   Qi, Rong ^a  

^a SHENYANG MEDICAL COLLEGE   (China)

^b NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^c LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTERASE; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; POPULATION GENETICS; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; BASE SEQUENCE; CHINA; DNA PRIMERS; DNA REPAIR; FEMALE; GLYCINE; HUMANS; LUNG NEOPLASMS; LYSINE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

RODENTIA; XERODERMA PIGMENTOSUM;

EID: 33746712334     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.03.008     Document Type: Article

References (43)

1. Winsey S.L., Haldar N.A., Marsh H.P., Bunce M., Marshall S.E., Harris A.L., Wojnarowska F., and Welsh K.I. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma. Cancer Res 60 (2000) 5612-5616
2. Bohr V.A. DNA repair fine structure and its relations to genomic instability. Carcinogenesis 16 (1995) 2885-2892
3. Mohrenweiser H.W., and Jones I.M. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation?. Mutat Res 400 (1998) 15-24
4. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair gene and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11 (2002) 1513-1530
5. Benhamou S., and Sarasin A. ERCC2/XPD polymorphisms and cancer risk. Mutagenesis 17 (2002) 463-469
6. Coin F., Marinoni J.C., Rodolfo C., Fribourg S., Pedrini A.M., and Egly J.M. Mutations in XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nature Genet 20 (1998) 184-188
7. Shen M.R., Jones I.M., and Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58 (1998) 604-608
8. Benhamou S., and Sarasin A. ERCC2/XPD polymorphisms and lung cancer. Am J Epidemiol 161 (2005) 1-14
9. Sturgis E.M., Zheng R., Castillo E.J., Eicher S.A., Chen M., Strom S.S., Spitz M.R., and Wei Q. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 21 (2000) 2219-2223
10. Liang G., Xing D., Miao X., Tan W., Yu C., Lu W., and Lin D. Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Int J Cancer 105 (2003) 669-673
11. Vogel U., Laros I., Jacobsen N.R., Thomsen B.L., Bak H., Olsen A., Bukowy Z., Wallin H., Overvad K., Tjonneland A., Nexo B.A., and Raaschou-Nielsen O. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat Res 546 (2004) 65-74
12. Yu H.P., Wang X.L., Sun X., Su Y.H., Wang Y.J., Lu B., Shi L.Y., Xiong C.L., Li Y.Y., Li F., and Xu S.Q. Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma. Cancer Genet Cytogenet 154 (2004) 10-15
13. Baccarelli A., Dalista D., Minghetti P., Marinelli B., Albetti B., Tseng T., Hedayati M., Grossman L., Landi G., Struewing J.P., and Landi M.T. XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br J Cancer 90 (2004) 497-502
14. Dybdahl M., Vogel U., Frentz G., Wallin H., and Nexo B.A. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 8 (1999) 77-81
15. Vogel U., Olsen A., Wallin H., Overvad K., Tjonneland A., and Nexo B.A. Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucasians after age 50. Cancer Detect Prev 29 (2005) 209-214
16. Tomescu D., Kavanagh G., Ha T., Campbell H., and Melton D.W. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22 (2001) 403-408
17. Chen S., Tang D., Xue K., Xu L., Ma G., Hsu Y., and Cho S.S. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 23 (2002) 1321-1325
18. Vogel U., Hedayati M., Dybdahl M., Grossman L., and Nexo B.A. Polymorphisms of the DNA repair gene XPD: correlation with risk of basal cell carcinoma revisited. Carcinogenesis 22 (2001) 899-904
19. Shen M., Hung R.J., Brennan P., Malaveille C., Donato F., Placidi D., Carta A., Hautefeuille A., Boffetta P., and Porru S. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 12 (2003) 1234-1240
20. Matullo G., Guarrera S., Carturant S., Peluso M., Malaveille C., Davico L., Piazza A., and Vineis P. DNA repair gene polymorphisms, bulky DNA adducts in white blood cell and bladder cancer in a case-control study. Int J Cancer 92 (2001) 562-567
21. Caggana M., Kilgallen J., Conroy J.M., Wiencke J.K., Kelsey K.T., Miike R., Chen P., and Wrensch M.R. Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Biomarkers Prev 10 (2001) 355-360
22. Park J.Y., Lee S.Y., Jeon H.S., Park S.H., Bae N.C., Lee E.B., Cha S.I., Park J.H., Kam S., and Kim I.S. Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. Lung Cancer 36 (2002) 15-16
23. Misra R.R., Ratnasinghe D., Tangrea J.A., Virtamo J., Andersen M.R., Barrett M., Taylor P.R., and Albanes D. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smoking in Finland. Cancer Lett 191 (2003) 171-178
24. Spitz M.R., Wu X., Wang Y., Wang L.E., Shete S., Amos C.I., Guo Z., Lei L., Mohrenweiser H., and Wei Q. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 61 (2001) 1354-1357
25. Butkiewicz D., Rusin M., Enewold L., Shields P.G., Chorazy M., and Harris C.C. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 22 (2001) 593-597
26. Hu Z., Wei Q., Wang X., and Shen H. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer 46 (2004) 1-10
27. Justenhoven C., Hamann U., Pesch B., Harth V., Rabstein S., Baisch C., Vollmert C., Illig T., Ko Y.D., Bruning T., and Brauch H. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev 13 (2004) 2059-2064
28. Yeh C.C., Sung F.C., Tang R., Chang-Chieh C.R., and Hsieh L.L. Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer 28 (2005) 12
29. Mechanic L.E., Marrogi A.J., Welsh J.A., Bowman E.D., Khan M.A., Enewold L., Zheng Y.L., Chanock S., Shields P.G., and Harris C.C. Polymorphisms in XPD and TP53 and mutation in human lung cancer. Carcinogenesis 26 (2005) 597-604
30. Popanda O., Schattenberg T., Phong C.T., Butkiewicz D., Risch A., Edler L., Kayser K., Dienemann H., Schulz V., Drings P., Bartsch H., and Schmezer P. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25 (2004) 2433-2441
31. Chen Z. Medical genetics. 1st ed. (2001), People's Hygienic Press, Beijing 262-3
32. Yang L., Parkin D.M., Li L., and Chen Y. Time trend in cancer mortality in China: 1987-1999. Int J Cancer 106 (2003) 771-783
33. Xing D., Tan W., Wei Q., and Lin D. Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer 38 (2002) 123-129
34. Yin J., Li J., Ma Y., Guo L., Wang H., and Vogel U. The DNA repair gene ERCC2/XPD polymorphism Arg156Arg (A22541C) and risk of lung cancer in a Chinese population. Cancer Lett 223 (2005) 219-226
35. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15 (2005) 97-98
36. Hamajima N., Saito T., Matsuo K., Suzuki T., Nakamura T., Matsuura A., Okuma K., and Tajima K. Genotype frequencies of 50 polymorphisms for 241 Japanese non-cancer patients. J Epidemiol 12 (2002) 229-236
37. Hou S.M., Falt S., Angelini S., Yang K., Nyberg F., Lamber T.B., and Heminki K. The DNA variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 23 (2002) 599-603
38. Davd-Beabes G.L., Lunn R.M., and London S.J. No association between the XPD (Lys751Gln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 10 (2001) 911-912
39. Zhou W., Liu G., Miller D.P., Thurston S.W., Xu L.L., Wain J.C., Lynch T.J., Su L., and Christiani D.C. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 62 (2002) 1377-1381
40. Yin J., Rockenbauer E., Hedayati M., Jacobsen N.R., Vogel U., Grossman L., Bolund L., and Nexo B.A. Multiple single nucleotide polymorphisms on human chromosome 19q13.2-3 associate with risk of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 11 (2002) 1449-1453
41. Nexo B.A., Vogel U., Olsen A., Ketelsen T., Bukowy Z., Thomsen B.L., Wallin H., Overvad K., and Tjonneland A. A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55. Carcinogenesis 24 (2003) 899-904
42. Ardlie K., Liu-Cordero S.N., Eberle M.A., Daly M., Barrett J., Winchester E., Lander E.S., and Kruglyak L. Lower-than-expected linkage disequilibrium between tightly linked markers in humans suggests a role for gene conversion. Am J Hum Genet 69 (2001) 582-589
43. King C.R., Yu J., Freimuth R.R., McLeod H.L., and Marsh S. Interethnic variability of ERCC2 polymorphisms. Phamacogenomics J 5 (2005) 54-59